Form 8-K - Current report:
SEC Accession No. 0001140361-25-008178
Filing Date
2025-03-12
Accepted
2025-03-11 20:38:50
Documents
15
Period of Report
2025-03-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20045255_8k.htm   iXBRL 8-K 26604
2 EXHIBIT 99.1 ef20045255_ex99-1.htm EX-99.1 13600
6 image00001.jpg GRAPHIC 3657
  Complete submission text file 0001140361-25-008178.txt   184724

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20250311.xsd EX-101.SCH 3973
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20250311_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20250311_pre.xml EX-101.PRE 16038
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20045255_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 25729693
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)